Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001178913-24-002709
Filing Date
2024-08-20
Accepted
2024-08-20 14:36:44
Documents
2
Group Members
SPHERA GLOBAL HEALTHCARE GP LTD.SPHERA GLOBAL HEALTHCARE MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G zk2431899.htm SC 13G 73144
2 EXHIBIT 1 exhibit_1.htm EX-99 5546
  Complete submission text file 0001178913-24-002709.txt   80556
Mailing Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520
Business Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SC 13G

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86953 | Film No.: 241224557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)